Insulin-like growth factor 2 (IGF2) protects against Huntington’s disease through the extracellular disposal of protein aggregates
Paula García-Huerta, Paulina Troncoso-Escudero, Di Wu, Arun Thiruvalluvan, Marisol Cisternas-Olmedo, Daniel R. Henríquez, Lars Plate, Pedro Chaná‐Cuevas, Cristian Saquel, Peter Thielen, Kenneth Longo, Brad J. Geddes, Gerardo Z. Lederkremer, Neeraj Sharma, Marina Shenkman, Swati Naphade, S. Pablo Sardi, Carlos Spichiger, Hans Richter, Felipe A. Court, Kizito‐Tshitoko Tshilenge, Lisa Ellerby, R. Luke Wiseman, Christian González‐Billault, Steven Bergink, René L. Vidal, Claudio Hetz
Topics & Concepts
Huntington's diseaseExtracellularInsulin-like growth factorGrowth factorInsulinDiseaseInsulin-like growth factor 2Cell biologyInternal medicineChemistryEndocrinologyBiologyMedicineReceptorGenetic Neurodegenerative DiseasesEndoplasmic Reticulum Stress and DiseaseMuscle Physiology and Disorders